Understanding the brain in real time remains one of the most complex challenges in modern medicine. Monitoring cerebral oxygenation can be critical in clinical environments such as neurosurgery, intensive care, and emergency medicine, helping to guide interventions and improve patient outcomes.
However, many established techniques have clear limitations: Invasive approaches like intracranial pressure (ICP) monitoring carry inherent risks and aren’t suitable for all patients, while imaging modalities such as MRI and CT require comparatively long acquisition times, preventing continuous real-time monitoring, as well as being immobile and resource-intensive.
Photonics is playing an increasingly important role in meeting this need. Emerging approaches such as functional near-infrared spectroscopy (fNIRS) offer a combination of accessibility and meaningful physiological measurements.
The Optical Principle
The foundations of fNIRS were built on the interaction between near-infrared light and biological tissues. Light in the wavelength range of approximately 650 to 1100 nm can penetrate biological tissue, providing a non-invasive optical window into underlying physiological processes.1 fNIRS uses this principle to measure changes in hemoglobin concentration in the brain. By emitting multiple wavelengths of near-infrared light and detecting the returning signal, it becomes possible to distinguish between oxygenated and deoxygenated hemoglobin, reflecting regional changes in neuronal activation.1,2
However, in practice, only a small fraction of the emitted light reaches the detector, so the resulting signal is weak and highly sensitive to noise. This makes measurements technically demanding.
Newer optical approaches are also expanding the scope of non-invasive brain monitoring. Techniques such as time-domain near-infrared spectroscopy (TD-NIRS) and diffuse correlation spectroscopy (DCS) can provide additional insights into cerebral perfusion, blood flow, and hemodynamic function, broadening the physiological information available through optical neuromonitoring.3
Engineering Challenges in Optical Brain Monitoring
Realizing the potential of fNIRS for brain monitoring relies on overcoming a complex set of engineering constraints. One of the primary challenges is signal attenuation and scattering. As near-infrared light travels through the scalp, skull, and brain tissue, it’s both absorbed and diffusely scattered, resulting in a substantial loss of signal intensity.
By the time light reaches the detector, only a small fraction of the original photons remains, making the system highly sensitive to noise and requiring detectors with high-sensitivity and low-noise characteristics. Closely related to this is the trade-off between measurement depth and signal strength, where the separation between the light source and detector determines how deeply light penetrates the tissue.
Larger separations allow interrogation of deeper brain regions but reduce the intensity of the detected signal. Shorter separations provide stronger signals that are more heavily influenced by superficial tissues. Balancing this is a key aspect of system design.
Another challenge arises from the mixed nature of the detected signal. Measurements often include contributions from extracerebral tissues—such as the scalp and skull—in addition to the brain itself.
This issue has been recognized since early clinical investigations, which highlighted extracranial signal contamination as a key limitation, while also demonstrating that near-infrared measurements can still reflect intracranial hemodynamic changes under controlled conditions.4
Isolating the cerebral component therefore requires careful system design and signal processing, particularly in applications where accuracy is critical.
Real-world variability further complicates measurement. Factors such as skin tone, hair, and movement can affect optical coupling and signal quality. Furthermore, motion (such as during ambulance rides or long-term monitoring) can introduce significant noise. Ambient light interference must also be managed to ensure reliable operation outside of controlled environments.
Finally, the physical interface between the system and the patient plays a crucial role. Maintaining consistent contact between sensors and skin is essential for repeatable measurements.
This places constraints on sensor design, attachment mechanisms, and overall system ergonomics, particularly for wearable or long-duration applications. These challenges put significant demands on both the optical components and the overall system architecture.
From Components to Complete Systems
Specialized optical components designed to operate in the near-infrared spectrum are at the heart of fNIRS systems. Light sources typically include lasers and LEDs capable of delivering stable outputs at specific wavelengths, while detectors such as silicon and InGaAs photodiodes, avalanche photodiodes (APDs), and silicon photomultipliers (SiPMs or MPPCs) are used to capture the returning signal.
System performance depends on several key parameters. Wavelength selection, typically in the 650 to 1100 nm range, is critical for differentiating between oxygenated and deoxygenated hemoglobin, as well as allowing depth selectivity. Detector sensitivity and noise characteristics directly influence the ability to capture weak signals, while dynamic range determines how well the system can accommodate varying signal intensities.
Modern systems often incorporate multiple source-detector pairs arranged across the scalp, enabling spatial mapping of brain activity. While this increases the amount of information that can be captured, it adds complexity in terms of synchronization, data acquisition, and signal processing.
As a result, successful implementation depends not only on individual component performance, but on how these elements are integrated into a complete system. Customization is frequently required to meet the needs of specific applications, whether prioritizing depth sensitivity, spatial resolution, portability, or user comfort.
Achieving the right balance between these factors is central to delivering meaningful and reliable measurements. When these challenges are addressed, fNIRS can be applied across a growing range of clinical and research settings.
Clinical and Research Applications of fNIRS
One of the main strengths of fNIRS is its flexibility. Unlike many traditional neuroimaging techniques, it can be deployed in a wide range of environments, from controlled laboratory studies to bedside monitoring.
In clinical settings, fNIRS is increasingly explored for monitoring cerebral oxygenation during surgery and in critical care. Continuous measurement of oxygenation in these settings could provide early warning of physiological deterioration, particularly in cases such as traumatic brain injury or compromised cerebral perfusion.
Emerging research suggests that features derived from optical signals may correlate with changes in intracranial pressure, highlighting the potential for non-invasive alternatives to current monitoring techniques. Earlier clinical studies have also shown that fNIRS can track cerebral hemodynamic changes in surgical settings, reinforcing the physiological relevance of these measurements.4
Beyond acute care, fNIRS has also shown benefits in neuroscience research, particularly in populations where other methods are difficult to apply. Its non-invasive nature and tolerance to movement compared to techniques like MRI make it especially suitable for use in infants and children.
Because it doesn’t rely on behavioral responses, it enables investigation of brain function even in very early developmental stages.5 This has opened new avenues for studying cognitive development, social processing, and neurological conditions such as autism spectrum disorders. Researchers can examine how the brain responds to stimuli, how functional networks develop over time, and how these processes may differ in atypical development.5
This capability forms the foundation for more advanced imaging approaches, including higher resolution and three-dimensional brain mapping techniques.1,6 However, translating these capabilities into robust, clinically reliable systems requires careful consideration of the underlying technical challenges.
Beyond fNIRS
fNIRS focuses on hemodynamic responses, making it part of a broader landscape of brain monitoring technologies. Diffuse optical tomography (DOT) extends the principles of fNIRS by using multiple sources and detectors to reconstruct three-dimensional maps of brain activity. This approach provides improved spatial resolution and is widely used in research settings to study functional connectivity and brain organization.6
In contrast, magnetoencephalography (MEG) measures the magnetic fields generated by neuronal electrical activity. This allows for high temporal resolution and direct measurement of neural signals. However, conventional MEG systems are large, expensive, and require specialized environments.
Recent developments in optically pumped magnetometers (OPMs) are beginning to address these limitations. By enabling more compact and flexible MEG systems, OPMs allow the potential for improved patient comfort and broader accessibility. Together, these approaches highlight the expanding role of photonics in enabling new modalities for brain monitoring.
Enabling Continuous, Non-Invasive Brain Monitoring
Advances in both hardware and data analysis are beginning to unlock new possibilities for fNIRS. Research has shown that features extracted from optical signals can differentiate between physiological states associated with changes in intracranial pressure, achieving promising levels of sensitivity in early-stage studies.
While these approaches are still under development, they point toward a future when continuous, non-invasive brain monitoring could complement existing techniques. Improvements in sensor design and detector performance are helping to improve signal quality and reliability, while there’s a clear trend toward more portable and wearable systems.
This enables monitoring to move beyond traditional clinical environments, with potential applications in bedside, ambulatory, and remote settings. Integration with other modalities, such as electroencephalography (EEG), also offers opportunities to combine complementary information and improve insights into brain activity.
Illuminating the Future of Brain Monitoring
The demand for accessible, real-time brain monitoring continues to grow, driven by the need for earlier intervention and more personalized care. Photonics-based technologies play an increasingly important role in meeting this need, enabling new approaches that combine non-invasiveness with meaningful physiological insights. fNIRS illustrates both the progress that’s been made and the challenges that remain.
While its portability and versatility open new possibilities, achieving consistent, high-quality measurements in real-world settings requires continued innovation in both system design and application development. Progress in this field will depend on close collaboration between researchers, clinicians, and photonics experts. By combining application expertise with advances in optical technologies, it’s possible to move closer to reliable, non-invasive brain monitoring that can be applied at scale.
source: MPO
